Henry Y. Wang

Biography

  Education: Massachusetts Institute of Technology PhD ’77 MS ’74 Iowa State University BS ’72   Courses Taught: ChE 343 – Separation Processes ChE 360 – Chemical Engineering Laboratory I ChE 460 – Chemical Engineering Laboratory II ChE 517 (MFG 517) – Biochemical Engineering ChE 519 (Pharm 519) – Pharmaceutical Engineering ChE 596 (Pharm 596) – Health Science and Engineering Seminar ChE 597 (Pharm 597) – Regulatory Issues for Scientists, Engineers, and Managers ChE 598 – Advanced Special Topics in Chemical Engineering

Research Interest

Biopharmaceutical Engineering. The global healthcare sector, comprised of pharmaceutical, biotechnology, medical device companies, regulatory agencies such as FDA, healthcare providers, insurers and consumers, is a dynamic and unique entity, rapidly moving towards highly automated and electronic environments in which the storage, management, and use of complex information is essential for success. Some of the key research topics in Biopharmaceutical Engineering include: design of personalized medicine for global health, rapid vaccine and drug development during pandemics, and regulatory science and engineering for biomedical innovation. Bioprocessing for Sustainable Development. A sustainable and environmentally sound economy requires the development of a new generation of ecologically compatible manufacturing processes. Bioprocessing and biotechnology should have a significant impact on this development. New and sustainable bioprocesses can be designed to manufacture biofuels, specialty chemicals and pharmaceuticals. A systematic approach of developing a reconfigurable network for biomass to bioenergy/bioproduct processes by integrating both chemical and biological reactions and the use of advanced manufacturing science with process intensification is currently being investigated.